Unison Medicare And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 30-07-2024
- Paid Up Capital ₹ 0.27 M
as on 30-07-2024
- Company Age 30 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -1.41%
(FY 2023)
- Profit -769.52%
(FY 2023)
- Ebitda -92.71%
(FY 2023)
- Net Worth -7.75%
(FY 2023)
- Total Assets -4.97%
(FY 2023)
About Unison Medicare And Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.27 M, as per Ministry of Corporate Affairs (MCA) records.
Ishwarprasad Gilada, Sindhu Gilada, Prapti Gilada, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110MH1994PTC077543
- Company No.
077543
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Apr 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Unison Medicare And Research Centre?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Trupti Gilada  | Additional Director | 05-Jun-2019 | Current |
| Ishwarprasad Gilada | Director | 05-Apr-1994 | Current |
| Sindhu Gilada | Director | 22-Jul-2009 | Current |
| Prapti Gilada | Additional Director | 05-Jun-2019 | Current |
Financial Performance and Corporate Structure Insights of Unison Medicare And Research Centre.
Unison Medicare And Research Centre Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.41% decrease. The company also saw a substantial fall in profitability, with a 769.52% decrease in profit. The company's net worth dipped by a decrease of 7.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unison Medicare And Research Centre?
In 2023, Unison Medicare And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Innova Life Sciences Private LimitedActive 20 years 11 monthsIshwarprasad Gilada is a mutual person
Niknim Estates Private LimitedActive 30 years 8 monthsIshwarprasad Gilada and Sindhu Gilada are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Unison Medicare And Research Centre?
Unlock and access historical data on people associated with Unison Medicare And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unison Medicare And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unison Medicare And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
